JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Income Tax Expense Over TimeStable
Percentile Rank43
3Y CAGR-12.8%
5Y CAGR-15.5%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
-12.8%/yr
vs -0.8%/yr prior
5Y CAGR
-15.5%/yr
Consistent
Acceleration
-12.0pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
2025$1.44B+47.5%
2024$978.00M+5.5%
2023$927.00M-57.4%
2022$2.17B-26.8%
2021$2.97B-11.3%
2020$3.35B+2.5%
2019$3.27B+45.5%
2018$2.25B+37.8%
2017$1.63B+4.9%
2016$1.55B-